Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Altimmune, Inc. (ALT) had Return on Equity of -76.97% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.02M |
|
$-95.06M |
|
-- |
|
$0.02M |
|
$103.19M |
|
$-103.17M |
|
$8.11M |
|
$-95.06M |
|
$-95.06M |
|
$-95.06M |
|
$-95.06M |
|
$-95.06M |
|
$-95.06M |
|
$-103.17M |
|
$-106.78M |
|
71.00M |
|
71.00M |
|
$-1.34 |
|
$-1.34 |
|
| Balance Sheet Financials | |
$137.25M |
|
$0.41M |
|
$2.05M |
|
$139.31M |
|
$10.47M |
|
-- |
|
$5.33M |
|
$15.80M |
|
$123.51M |
|
$123.51M |
|
$123.51M |
|
72.35M |
|
| Cash Flow Statement Financials | |
$-79.85M |
|
$-28.39M |
|
$10.04M |
|
$135.16M |
|
$36.97M |
|
$-98.19M |
|
$14.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-515860.10% |
|
-515860.10% |
|
-533920.00% |
|
-475295.00% |
|
-475295.00% |
|
$-79.85M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.01 |
|
0.06M |
|
|
Return on Equity |
-76.97% |
-76.97% |
|
-68.24% |
|
-76.97% |
|
$1.71 |
|
$-1.12 |
|
$-1.12 |
|